About Us

Establishment of Larix

Larix International is a private limited company involved in publishing Open Access Science and medicine related journals. The company is run by a team of dedicated editors, reviewers and authors. Over the years, Larix has evolved into one of forerunner in the publishing industry around the world. We continue to lead through the visions of technology, people, and innovation.

Why to publish with Larix?

At present, Larix International scope is to publish high-quality original research papers, case reports and other manuscripts. We promote scientific research with the help of stringent Peer-Review process. We are empowered by eminent group of editors and reviewers. The Editorial Board oversee the stringent multi-level Peer-Review process including evaluating submissions, selecting reviewers and assessing their comments and making editorial decisions.

We foster the open-access policy strongly and offer unrestricted access to the papers published, reproduction and distribution of the manuscripts in any medium, provided the original work is properly cited.

We are dedicated to offer researchers a broad range of services and are well known for providing online publication in an efficient and effective manner.

Vision of Larix

Larix wishes to establish a future trend for growth advancement in science, medicine and technology with the help of scholarly manuscripts. We wish to promote Open Access to facilitate the research literatures available on the public domain free-of-cost and to permit reading or downloading for any lawful purpose.

Mission of Larix

Larix works with a mission to publish, discuss and analyze invaluable research, applications and expert opinions in the versatile field of science, medicine and technology. We aim to bring important scientific works to a wide international audience and therefore only publish original papers with strong and analytical messages that advance our understanding of scientific principles. We ensure that the research presented in the manuscripts must be descriptive, providing insights into scope of the journal.

Editors-in-Chief


Editors

Prof . Dr Md. Abdul Alim Al-Bari
Department of Pharmacy , University of Rajshahi , Bangladesh
Dr . Dr. Tarek Mohamed Kamal Mohamed Metawie ,
Pharmaceutical Sciences , Cairo University , Egypt
Dr . Sandip Narayan Chakraborty Research Asst II
Translational Molecular Pathology , UT MD Anderson Cancer Center , USA
Prof . Dr. R. Mannavalan M. Pharm., Ph.D
Department of Pharmacy , Annamalai University , India
Dr . R. Vijay Kumar M.Pharm., Ph.D
Team leader , APPCO Pharma , India
Dr . Dr. Venkatesha Udupa Senior General Manager
Glenmark Research Centre , Glenmark Pharmaceuticals Limited , India
Dr . Shaik Harun Rasheed M.Pharm., Ph.D., L.L.B, FAGE, A.I.C
Professor & Head , MRM College of Pharmacy , India
Dr . Sunitha Reddy M. Pharm., Ph.D., FPGEE, NABP(Mem), R.Ph. USA
BOS Chairperson, CPS, IST , JNTU , India
Dr . M. Ajitha M. Pharm., PhD
Professor & OIE , Institute of Science and Technology, JNT-University , India
Dr . Sadanandam Palle
DST SERB Fast Track Young Scientist & Co-PI , Institute of Science & Technology, JNT University , India